|
Mr. Kay is Group Vice President of New Market Development / Strategic Planning, Endosurgery at Boston Scientific Corporation (BSC). The Endosurgery Group represents over $1 billion in annual sales and Henry is responsible for the Group strategic plan and assessing external investment and acquisition opportunities. He has 30 years of experience in the medical industry and has held senior management positions at major pharmaceutical companies including Schering-Plough, American Home Products and Allergan. Henry is a fellow of the Royal Society of Medicine (UK) and holds B.S. and M.S. degrees in Chemistry from Rutgers University and an M.B.A. in International Marketing from Seton Hall University. | 